©Hélène Bottarel/Groupe-6
DiogenX raises €27.5M Series A financing to advance its first-in-class regenerative treatment for type 1 diabetes towards clinical development
Benjamin Charles, CEO at DiogenX – © DiogenX
Ciliatech raises €3.5M in Series A funding
© Studio CAP PHOTO
Minagro raises €1.2M under new management
French biotech Calida Therapeutics launches with seed funding,leveraging US academic research in thrombo-inflammatory disorders
Kayentis raises further €5M to boost US activities
Previa Medical raises €2.1 million for AI solution to prevent sepsis
BiPER Therapeutics raises €1.25 million in seed funding to develop first-in-class small molecules to treat gastrointestinal cancers
Dianosic raises €4.7M to bring treatment for chronic rhinitis into clinical trial
